Exposure of R169 controls protein C activation and autoactivation

Blood

Volumn 120, Issue 3, 2012, Pages 664-670

  Pozzi, Nicola ^a   Barranco Medina, Sergio ^a   Chen, Zhiwei ^a   Di Cera, Enrico ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN C; PROTHROMBIN; THROMBIN; THROMBOMODULIN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 84864123309     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-03-415323     Document Type: Article

References (50)

1. Page MJ, Di Cera E. Serine peptidases: classification, structure and function. Cell Mol Life Sci. 2008;65(7):1220-1236.
2. Krem MM, Di Cera E. Evolution of enzyme cascades from embryonic development to blood coagulation. Trends Biochem Sci. 2002;27(2):67-74. (Pubitemid 34164321)
3. Gros P, Milder FJ, Janssen BJ. Complement driven by conformational changes. Nat Rev Immunol. 2008;8(1):48-58.
4. Gohara DW, Di Cera E. Allostery in trypsin-like proteases suggests new therapeutic strategies. Trends Biotechnol. 2011;29(11):577-585.
5. Arlaud GJ, Barlow PN, Gaboriaud C, Gros P, Narayana SV. Deciphering complement mechanisms: the contributions of structural biology. Mol Immunol. 2007;44(16):3809-3822. (Pubitemid 47332622)
6. Ponnuraj K, Xu Y, Macon K, Moore D, Volanakis JE, Narayana SV. Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase. Mol Cell. 2004;14(1):17-28. (Pubitemid 38469906)
7. Jing H, Macon KJ, Moore D, DeLucas LJ, Volanakis JE, Narayana SV. Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D. EMBO J. 1999;18(4):804-814. (Pubitemid 29082260)
8. Narayana SV, Carson M, el-Kabbani O, et al. Structure of human factor D: a complement system protein at 2.0 A resolution. J Mol Biol. 1994;235(2):695-708.
9. Forneris F, Ricklin D, Wu J, et al. Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science. 2010;330(6012):1816-1820.
10. Jing H, Babu YS, Moore D, et al. Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. J Mol Biol. 1998;282(5):1061-1081. (Pubitemid 28468203)
11. Banner DW, D'Arcy A, Chene C, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996;380(6569):41-46. (Pubitemid 26076234)
12. Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol. 2003;23(1):17-25. (Pubitemid 36091621)
13. Di Cera E. Thrombin. Mol Aspects Med. 2008;29(4):203-254.
14. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem. 1982;257(2):859-864. (Pubitemid 12110218)
15. Ye J, Esmon NL, Esmon CT, Johnson AE. The active site of thrombin is altered upon binding to thrombomodulin: two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J Biol Chem. 1991;266(34):23016-23021. (Pubitemid 21908753)
16. Le Bonniec BF, Esmon CT. Glu-192-Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci U S A. 1991;88(16):7371-7375. (Pubitemid 21915153)
17. Le Bonniec BF, MacGillivray RT, Esmon CT. Thrombin Glu-39 restricts the P′3 specificity to nonacidic residues. J Biol Chem. 1991;266(21):13796- 13803. (Pubitemid 21907422)
18. Ehrlich HJ, Grinnell BW, Jaskunas SR, Esmon CT, Yan SB, Bang NU. Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin. EMBO J. 1990;9(8):2367-2373.
19. Richardson MA, Gerlitz B, Grinnell BW. Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant. Nature. 1992;360(6401):261-264.
20. Fuentes-Prior P, Iwanaga Y, Huber R, et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature. 2000;404(6777):518-525. (Pubitemid 30186897)
21. Adams TE, Li W, Huntington JA. Molecular basis of thrombomodulin activation of slow thrombin. J Thromb Haemost. 2009;7(10):1688-1695.
22. Vindigni A, White CE, Komives EA, Di Cera E. Energetics of thrombin-thrombomodulin interaction. Biochemistry. 1997;36(22):6674-6681. (Pubitemid 27242325)
23. Hayashi T, Zushi M, Yamamoto S, Suzuki K. Further localization of binding sites for thrombin and protein C in human thrombomodulin. J Biol Chem. 1990;265(33):20156-20159. (Pubitemid 120013989)
24. Gerlitz B, Grinnell BW. Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin. J Biol Chem. 1996;271(37):22285- 22288. (Pubitemid 26304654)
25. Xu H, Bush LA, Pineda AO, Caccia S, Di Cera E. Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. J Biol Chem. 2005;280(9):7956-7961. (Pubitemid 40349693)
26. Yang L, Manithody C, Rezaie AR. Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci U S A. 2006;103(4):879-884. (Pubitemid 43212190)
27. Yang L, Prasad S, Di Cera E, Rezaie AR. The conformation of the activation peptide of protein C is influenced by Ca2+ and Na+ binding. J Biol Chem. 2004;279(37):38519-38524. (Pubitemid 39296005)
28. Wu QY, Sheehan JP, Tsiang M, Lentz SR, Birktoft JJ, Sadler JE. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin- binding activities of human thrombin. Proc Natl Acad Sci U S A. 1991;88(15):6775-6779. (Pubitemid 21915032)
29. Pozzi N, Chen Z, Zapata F, Pelc LA, Barranco-Medina S, Di Cera E. Crystal structures of prethrombin-2 reveal alternative conformations under identical solution conditions and the mechanism of zymogen activation. Biochemistry. 2011;50(47):10195-10202.
30. Marino F, Pelc LA, Vogt A, Gandhi PS, Di Cera E. Engineering thrombin for selective specificity toward protein C and PAR1. J Biol Chem. 2010;285(25):19145-19152.
31. Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem. 1992;267(36):26104- 26109. (Pubitemid 23014023)
32. Dang OD, Vindigni A, Di Cera E. An allosteric switch controls the procoagulant and anticoagulant activities of thrombin. Proc Natl Acad Sci U S A. 1995;92(13):5977-5981.
33. Rezaie AR, Yang L. Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Proc Natl Acad Sci U S A. 2003;100(21):12051- 12056. (Pubitemid 37271513)
34. Otwinowski Z, Minor W. Processing of x-ray diffraction data collected by oscillation methods. Methods Enzymol. 1997;276:307-326. (Pubitemid 27085611)
35. Bailey S. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994;50:760-763.
36. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(12):2126-2132. (Pubitemid 41742764)
37. Morris AL, MacArthurMW, Hutchinson EG, Thornton JM. Stereochemical quality of protein structure coordinates. Proteins. 1992;12(4):345-364.
38. Dang QD, Di Cera E. Chromogenic substrates selective for activated protein C. Blood. 1997;89(6):2220-2222. (Pubitemid 27132142)
39. Miletich JP, Broze GJ Jr. Beta protein C is not glycosylated at asparagine 329: the rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem. 1990; 265(19):11397-11404.
40. Wang D, Bode W, Huber R. Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol. 1985;185(3):595-624. (Pubitemid 15241167)
41. Bode W, Turk D, Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alphathrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1992;1(4):426-471. (Pubitemid 23016868)
42. Gandhi PS, Chen Z, Di Cera E. Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1. J Biol Chem. 2010;285(20):15393-15398.
43. Stubbs MT, Oschkinat H, Mayr I, et al. The interaction of thrombin with fibrinogen: a structural basis for its specificity. Eur J Biochem. 1992;206(1):187-195.
44. Sadasivan C, Yee VC. Interaction of the factor XIII activation peptide with alpha-thrombin: crystal structure of its enzyme-substrate analog complex. J Biol Chem. 2000;275(47):36942-36948. (Pubitemid 32002108)
45. Gandhi PS, Chen Z, Appelbaum E, Zapata F, Di Cera E. Structural basis of thrombin-PAR interactions. IUBMB Life. 2011;63(6):375-382.
46. Pineda AO, Carrell CJ, Bush LA, et al. Molecular dissection of Na+ binding to thrombin. J Biol Chem. 2004;279(30):31842-31853.
47. Cleary DB, Trumbo TA, Maurer MC. Proteaseactivated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface. Arch Biochem Biophys. 2002;403(2):179-188. (Pubitemid 34800200)
48. Di Cera E. Know your APC. Blood. 2009;113(23):5699-5700.
49. Friedrich R, Panizzi P, Fuentes-Prior P, et al. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature. 2003;425(6957):535-539. (Pubitemid 37237051)
50. Flick MJ, Chauhan AK, Frederick M, et al. The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. Blood. 2011;117(23):6326-6337.